RanLOS AB (RLOS-B) Fair Value & Analysis
Technology · SE · Market cap 27.0M SEK
Fair value as of: Jul 18, 2026
From 1 valuation models · updated 4 days ago
Share price −8.3% over the past month.
Price vs Fair Value (12 months)
12‑month range kr 1.85 – kr 4.50 · fair‑value band kr 0.3825 – kr 0.7225 · the kr 2.39 price screens above the kr 0.5780 fair value. As of Jul 18, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
RanLOS AB (RLOS-B) currently trades at kr 2.39, while our model-based Fair Value estimate is kr 0.5780, implying the stock looks roughly 75.8% overvalued today. We read business quality at 19/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 1.7M SEK. Revenue declined 83.1% year over year. It earns a return on equity of -59.8%. Fundamentals as of Jul 18, 2026
Our scenario range runs from kr 0.3825 (bear case) to kr 0.7225 (bull case); at kr 2.39, the current price sits above that range. The share trades about 60% below its 52-week high and 39% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -50% fair-value upside, at -76%, RLOS-B screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 18, 2026. TTM = trailing twelve months.
About the company
RanLOS AB (publ) provides test systems for vehicles, base stations, antennas, and other connected devices in Sweden. It offers RanLOS Sub-6 GHz test system for measuring devices, including vehicles and base stations; and RanLOS mmWave test system for measuring devices, such as mobile phones and base stations at higher frequencies. The company also provides RanLOS measurement software that controls instruments and positioners, as well as collects measurement data. RanLOS AB (publ) was incorporated in 2016 and is based in Mölndal, Sweden.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
RanLOS AB reported revenue of kr 575K in FY2025 versus kr 1.0M in FY2022, a compound −17.5%/yr. Reported net income was −kr 8.3M in FY2025.
Is RLOS-B fairly valued? → Check now
Similar stocks
10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Keyence Corporation KYCCF | $457.38 | $228.86 | -50% |
| Keysight Technologies, Inc KEYS | $324.00 | $92.23 | -72% |
| Garmin Ltd GRMN | $236.34 | $162.20 | -31% |
| Teledyne Technologies Incorporated TDY | $601.35 | $358.39 | -40% |
| Chroma ATE Inc 2360 | 2,565 TWD | 359.43 TWD | -86% |
| Hexagon AB HXGBF | $8.84 | $5.23 | -41% |
| MKS Inc MKSI | $316.07 | $53.74 | -83% |
| AVIC Chengdu Aircraft Company 302132 | ¥52.91 | ¥34.47 | -35% |
| Fortive Corporation FTV | $61.47 | $30.19 | -51% |
| Trimble Inc TRMB | $57.74 | $16.79 | -71% |
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is RanLOS AB (RLOS-B) undervalued?
What is the fair value of RLOS-B?
What is the quality score of RLOS-B?
What is the revenue of RanLOS AB (RLOS-B)?
What is the net profit margin of RLOS-B?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full RanLOS AB analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.